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Abstract 
Background Outcome assessment is mandated by the American College of Surgeons and the 
Royal College of Surgeons of England. The Trauma Audit and Research Network (TARN) in the 
United Kingdom (UK) publicly reports hospital performance. The TARN risk adjustment model 
uses a fractional polynomial transformation of the Injury Severity Score (ISS) as the measure of 
anatomic injury severity. The Trauma Mortality Prediction Model (TMPM) has been shown 
superior to ISS. We compared the anatomic injury components of the TARN model to TMPM. 
Methods Data are from the National Trauma Data Bank for 2011-2015. Probability of death was 
estimated for the TARN fractional polynomial transformation of ISS and compared to TMPM. 
The coefficients for the models were estimated using 80% of the data set, randomly selected. The 
remaining 20% of the data were used for model validation. TMPM and TARN were compared 
using calibration curves, measures of discrimination (area under ROC curves (AUROC)), 
proximity to the true model (Akaike Information Criterion (AIC)) and goodness of model fit 
(Hosmer-Lemeshow test (HL)). Results: N=438 058. There were no characteristic differences 
between derivation and validation groups. TMPM demonstrated preferable AUROC (0.882 for 
TMPM vs 0.845 for TARN) , AIC (18 204 vs 12 143), and better fit to the data (32.4 vs. 153.0) 
compared to TARN. 
Conclusions: TMPM had greater discrimination, proximity to the true model and goodness-of-fit 
than the anatomic injury component of TARN, TMPM should be considered for the injury 
severity measure for the comparative assessment of trauma centers in the UK. 
Keywords: Trauma, Injury Severity, Mortality Prediction, Anatomic Injury 
Background 
 The need for valid and reliable performance measures is vital as payers,  patients and 
accrediting bodies compare outcomes among hospitals or physicians. For trauma, outcome 
assessment is mandated by the American College of Surgeons (ACS) and the National Health 
Service of England (NHS). 1,2 The Trauma Audit and Research Network (TARN) in the United 
Kingdom (UK) and the Trauma Quality Improvement Program (TQIP) in the United States (US), 
each calculate a SDWLHQW¶V baseline predicted probability of dying from their traumatic injuries.3,4 
Central to the predicted probability of death is the extent of the anatomic injury from the 
traumatic event. 
 Recently, the Centers for Medicare and Medicaid Services (CMS), the largest healthcare 
payer in the US, adopted the Merit-based Incentive Payment System. This program determines 
payments, based in part, on healthcare quality measures, including data submission to qualified 
clinical data registries.5 Similarly, beginning in 2012, the NHS requires all major trauma centers 
VXEPLWGDWDWR7$51ZLWKLQGD\VIROORZLQJDSDWLHQW¶VGLVFKDUJHIURPWKHKRVSLWDODVSDUWRI
the National Tariff Payment System.6,7  In both the UK and US, the largest healthcare payers are 
the federal governments. The NHS LQFHQWLYL]HVSURYLGHUVDQGKRVSLWDOVWR³«DGHTXDWHO\
UHLPEXUVHFDUHWKDWLVKLJKTXDOLW\DQGFRVWHIIHFWLYH´8 In the US, the Hospital Value-Based 
Purchasing (VBP) program was incorporated as part of the Affordable Care Act.9 The VBP 
provides incentive payments for meeting performance standards.9,10 Injury severity plays an 
important role in healthcare finance because injury severity measurement adjusts for differences 
in patient case mix across hospitals caring for trauma patients. For example, the NHS best 
practices for trauma, anatomic injury severity differentiates two levels of payment by anatomic 
injury severity, ISS more than 8 and ISS 16 or greater.8 While CMS has outlined several 
measures specific to trauma care to be reported in a risk-stratified manner.11 
 Over the past 40 years, several methods of injury severity measurement have been 
proposed.12-16 However, the first such method, the Injury Severity Score (ISS)17, remains the 
most widely applied injury severity measure. The ISS is familiar to clinicians and researchers, 
which is probably the greatest contributor to its longevity. The ISS has functioned as a stand-
alone severity measure, and has also been incorporated into the leading models of trauma 
mortality, such as 18 TARN. Although it has remained the leading measure of injury severity 
since it was introduced, ISS has four major limitations. First, the ISS is based on the Abbreviated 
Injury Scale (AIS) severity values which are based on expert consensus, as opposed to being 
empirically derived. Second, ISS only accommodates the three worst injuries from three separate 
body regions. As such, it cannot account for two or more serious injuries in the same body 
region. Third, many hospitals do not DVVLJQ$,6FRGHVWRWKHLUSDWLHQWV¶LQMXULHVGHQRYR
Instead, they convert International Classification of Disease, 9th Revision, Clinical Modification 
(ICD-9) codes to AIS codes, thus reducing the accuracy of injury descriptions.19 Finally, Kilgo et 
al., described the ISS as "choppy" due to sharp increases or decreases with respect to mortality 
over incremental increases in ISS values.20 Of note, TARN uses a mathematical transformation 
of ISS to achieve better performance of their model. 
 The Trauma Mortality Prediction Models (TMPM) was developed as an empirically based 
alternative to ISS without the limitations of ISS. TMPM incorporates the SDWLHQW¶VILYHZRUVW
LQMXULHVDVSUHGLFWRUVRIDSDWLHQW¶VSUREDELOLWy of death using a logistic regression model. Prior 
work comparing TMPM to ISS and ISS-based injury severity models showed that TMPM was 
better able to predict mortality.21-23  The current analysis, expands on previous work by 
comparing TMPM to the anatomic injury elements of the prediction model used in TARN.  We 
hypothesized the TMPM would better predict survivors from fatalities given the limitations of 
the ISS. 
Methods 
Data Source 
 After obtaining approval from the institutional review board of Chandler Regional Medical 
Center, data from the National Trauma Data Bank (NTDB) for the years 2011 to 2015 were used 
in a retrospective cohort study. The NTDB contains data for nearly 7 million patient visits in 
more than 900 hospitals. The NTDB data are anonymized (i.e., all identifying information has 
been removed) to ensure confidentiality for patients, physicians, and hospitals participating in the 
NTDB.24 The outcome of interest was in-hospital death.  
 Patients were excluded if they were younger than 18 years old, were burn victims, their 
discharge status (alive or dead) was unknown, they were dead on arrival, or were missing ISS 
values, or AIS codes. We also excluded patients for whom the TMPM probability of death could 
not be calculated. The reliability and quality of injury documentation in the AIS lexicon is 
essential to this study. To this end, AIS codes were taken from the RDS_AISPCODE files as 
these were submitted by each hospital and least likely to contain codes mapped from ICDMAP-
90. Two additional exclusion criteria were applied using methods previously described.21 
Patients were excluded if they were from hospitals that admitted less than 300 patients per year 
or that used fewer than 20% of the available AIS codes.  
 Comparisons of surviving patients with those who expired were performed XVLQJWKHȤ2 and 
Kruskal-Wallis test statistics, as appropriate. Summary measures are presented as means with 
95% confidence intervals (95% CI), or as medians and interquartile ranges (IQR). 
 We compared the anatomic injury component of the TARN model to TMPM. TARN 2014 
model (Ps14) is based upon the ISS transformed by applying fractional polynomials. However, 
given the TARN Ps14 model was developed for data defined by the TARN inclusion criteria25, 
coefficients for the fractional polynomial transformation if ISS was computed de novo using 
NTDB data for this study. This model is as follows:  
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TMPM uses the worst five anatomic injuries coded as categorical variables along with two 
interaction terms.22 Coefficients for these seven TMPM terms for were computed for the study 
data. For the present study, the AIS lexicon was applied as the descriptor of anatomic injury. Of 
note however, the TMPM only uses the six digit "predot" code to define injuries and does not 
incorporate the AIS severity value in its computation of the probability of death. In contrast, the 
ISS metric is based exclusively on the expert consensus-based severity value.17 
 Using 80% of the data, the fractional polynomial transformation of the ISS was computed for 
the TARN model and coefficients for the TARN and TMPM models were estimated. The models 
were validated using the remaining 20% of the data set. 
 Measures of model performance included area under the receiver operating characteristic 
curve (AUROC) (C statistic) 26 and the Akaike information criterion  (AIC).27 The AUROC is a 
measure of sensitivity over 1-specificity. This measures the ability of a model to discriminate 
subjects having the outcome of interest, here mortality, from those who do not. As AUROC 
YDOXHVDSSURDFKWKHPRGHO¶VGLVFULPLQDWLRQLPSURYHV28 The AIC is a means to rank 
competing models and to estimate which model most closely approximates the hypothetical 
³WUXH´PRGHO of the phenomenon at hand. Generally, the model with the lowest associated AIC 
value is preferred. The Hosmer-Lemeshow (HL) goodness-of-fit test is a means to assess how 
well the model describes the data under analysis and inform the plausibility of the inferences 
drawn from the model.26 The HL test statistic was calculated for each score with eight degrees of 
freedom specified in the development sample and eight in the validation sample. Calibration 
curves were constructed for each model to assess monotonicity of the severity measures. 
Monotonicity describes incremental increases in the observed outcome, here mortality, as a 
consistent function of incremental increases in the injury severity values. Observed mortality was 
plotted versus expected mortality for TARN and TMPM. Of note, ISS  has 44 unique values for 
predicted probability of mortality, so the anatomic injury of the TARN model also has 44 distinct 
values. The TMPM produced 50 596 unique predicted probability values in the derivation group 
and 174 974 such values in the validation group. Given this level of granularity in the TMPM, 
the probabilities were grouped into deciles and plotted against the observed mortality for each 
decile. The 95% CI for the AUROC, AIC and HL for each severity score was computed using 1 
000 bootstrap samples of the dataset. There were no missing values for any model in the study. 
All statistical analysis was performed using Stata/MP version 14.2 (Stata Corporation, College 
Station, TX, USA). 
Results 
 After applying the exclusion criteria, 438 058 patients were included in the study. (Figure 1.) 
A total of 15 930 died (3.6%, 95% CI 3.6%-3.7%) during their hospitalization.  The mean age 
was 49.8 years old and the non-survivors were older (58.3, 58.0-58.7). White males represented 
the largest race-gender demographic group in the cohort (38.6%). Blunt mechanisms of injury 
were predominant (85.6%). Of these, falls were the majority (59.2%, 59.0%-59.4) followed by 
motor vehicle crashes, (25.7%, 25.5%-25.8%). Firearm-related injuries were associated with the 
highest mortality (8.4%, 7.8-8.9). The mean (SD) ISS and TMPM pDeath were 12 (6.9) and 
0.036 (0.092), respectively. (Table 1.) The range of predicted probabilities of death were 1.34 x 
10-6  - 1.0 and 0.002 ± 0.666 for TMPM and TARN, respectively. 
 There were 350 325 (80%) and 87 733 (20%) patients in the derivation and validation group, 
respectively. There were no significant differences between the derivation and validation groups 
with respect of age, sex, race/ethnicity, mechanisms of injury, median ISS, lengths of stay in the 
hospital or ICU, and rates of ICU admission and death.  
 Areas under the ROC curves (AUROC) were used to compare discrimination between 
survivors and non-survivors for the anatomic injury scores. TMPM exhibited better 
discrimination  compared to the TARN score in the derivation group (0.880, 0.880-0.880) and 
(0.841, 0.840-0.841) for TMPM and TARN, respectively. Similarly the AUROC was higher for 
TMPM in the validation group, (0.882, 0.882-0.882) versus (0.841, 0.840-0.841) for the 
fractional polynomial transformation of ISS used by TARN.  
 The Akaike information criterion was used to estimate each modelV¶SUR[LPLW\WRD
theoretical and unknown ³LGHDO´SUREDELOLW\RIPRUWDOLW\model. Given a group of prediction 
models, the best model is the one with the smallest AIC value. TMPM performed better in 
comparison to the fractional polynomial transformation of ISS used by TARN. Similarly, the HL 
test indicated TMPM demonstrated a lower value and thus, is a better fit to the data in the current 
study. (Table2.) 
 Calibration curves were plotted for TMPM and TARN. When the observed percent mortality 
is plotted over the proportion of mortality predicted by each of the 44 the discrete TARN ISS 
values, a non-monotonic pattern is observed in both the derivation and validation groups. It is 
noteworthy that the maximum probability of mortality predicted by the fractional polynomial 
transformation of ISS is approximately 0.6. This is likely due to the inherent limitations of ISS as 
the mortality among patients with ISS values of 75 in this study was 60%. (Figures 2 and 3)
Discussion 
 TMPM exhibited greater discrimination over a broader range of injury severity compared to 
the ISS-based anatomic injury component of TARN. Additionally, TMPM had the lower value 
for AIC indicating it more closely approximates a hypothetical "ideal" model. Moreover, the 
goodness-of-fit for TMPM surpassed that of TARN. In sum, the inherent limitations of the ISS 
which have been well documented in the literature20,21,29, are not overcome by mathematical 
transformation. Illness severity in trauma patients is measured using the probability of injury-
related mortality. Unlike TMPM in which injury severity is estimated empirically using the AIS 
so-called "predot" codes, the basis for the injury severity component of the TARN model is the 
AIS injury severity based on expert consensus.  Robust measures of injury severity are essential 
for performance benchmarking in order to improve outcomes in injured patients, and for 
incentivizing higher quality care in the NHS National Tariff Payment System and the Merit-
Based Incentive Payment System and VBP from CMS. Since anatomic injury is the fundamental 
element of trauma, the credible measurement of injury severity is essential to the evaluation of 
trauma care quality. In our study cohort, the AUROC was four percentage points greater for 
TMPM. Thus, TMPM accurately predicted mortality in 589 more patients than did the injury 
severity component of TARN. The cumulative weight of our findings suggest TARN should 
consider using TMPM to quantify injury severity instead of relying on an ISS-based severity 
measure.  
 Developed over 40 years ago by Baker, et al., ISS was adopted as the gold standard for 
measuring anatomic injury severity.17 It is the sum of the squared AIS severity values for the 
worst injury in each of three separate body regions. AIS severity values are based on expert 
consensus, as opposed to being empirically derived.  This algorithm results in 56 combinations 
of squared AIS severity scores that yield 44 possible unique ISS values. The ISS is relatively 
simple to calculate. This simplicity is very likely the key to its longevity. However, the ISS is 
also known for its non-monotonic nature due to steep peaks and valleys in mortality as the ISS 
value gets larger.20 More importantly, trauma care has advanced considerably in the 43 years 
since its publication as evidenced by the limitation of ISS in predicting mortality in the most 
severely injured patients. The TARN mortality model applies a sophisticated polynomial 
transformation of the ISS as the measure of anatomic severity. This improved the performance of 
the TARN model was demonstrated by Boumara, et al. in 2015.25 More recently, the TMPM was 
developed using an empiric regression-based approach to estimate injury severity, instead of 
relying on the expert-based estimates of injury severity used in ISS-based severity measures. 
 TMPM provides empirically derived probabilities of mortality using the AIS lexicon. 
Previous work comparing TMPM to ISS, maximum AIS score, New Injury Severity Score and 
the ICD-9-Based Injury Severity Score (ICISS) demonstrated that TMPM more accurately 
predicts trauma mortality.21  Although somewhat technical in our approach, it is important to 
assess the adequacy of the models prior to interpreting their results.30 Our current analysis is the 
first study to compare the anatomic component of TARN to TMPM and to find that TMPM 
performed best .   
 This study has several limitations. First, the NTDB is not population-based but is based on a 
self-selected group of trauma centers. Thus, our findings may not be generalizable to all trauma 
and non-trauma centers. However, a priori, there is no reason to believe our finding that empiric 
measures of injury severity out-perform measures of injury severity based on expert consensus 
would be limited to this sample of trauma patients. Second, the complete TARN model includes 
variables for age, Glasgow Coma Scale score and terms for the Charlson Comorbidity 
Index.25,31,32. Thus, the results presented in this paper represent the anatomic injury components 
only and no inference should be made regarding the predictive capabilities of the complete 
TARN model. However, we believe that the basis for accurate risk adjustment in trauma 
mandates accurate specification of the anatomic component of injury severity, before including 
measures of physiologic derangement and comorbidities.   
Conclusion 
 In the era of ubiquitous benchmarking of providers and institutions, risk adjustment in trauma 
based on the most accurate measure of injury severity is essential. TMPM more accurately 
captures the severity of traumatic injury than the ISS-based injury severity component of the 
TARN risk-adjustment model. The comparison of trauma systems, including those of separate 
nations, is only possible using a common injury lexicon and should be based on the most 
accurate method to quantify injury severity. The replacement of ISS with TMPM for national 
benchmarking efforts should be considered in the United Kingdom.  
  
Table 1. Characteristics of 438 058 patients* 
 All Patients Survivors Non-Survivors 
Total, per category, n (%) 438 058  422 128 (96.4) 15 930 (3.6) 
Age, mean (95% CI) 49.8 (49.8-49.9) 49.5 (49.4-49.6) 58.3 (58.0-58.7) 
Sex, Male, n (% ) 284 764 (65.0) 273 655 (96.1) 11 109 (3.9) 
Race/Ethnicity       
 White, non-Hispanic, n (% ) 277 794 (63.4) 267 350 (96.2) 10 444 (3.8) 
 Black, non-Hispanic, n (% ) 52 946 (12.1) 51 336 (97.0) 1 610 (2.9) 
 Hispanic/Latino, n (% ) 66 976 (15.3) 65 004 (97.1) 1 972 (3.0) 
 Race/other, n (% ) 40 342 (9.2) 38 438 (95.3) 1 904 (4.7) 
Alcohol Present, n (% ) 56 203 (12.8) 54 437 (96.9) 1 766 (3.1) 
Mechanism of Injury       
 Blunt, n (% ) 268 605 (85.6) 258 574 (96.3) 10 031 (3.7) 
  Fall, n (%) 159 053 (59.2) 152 407 (95.8) 6 646 (4.2) 
  Motor vehicle crash, n (%) 68 956 (25.7) 66 217 (96.0) 2 739 (4.0) 
 Penetrating, n (% ) 32 867 (10.5) 31 761 (96.6) 1 106 (3.4) 
  Firearm-related, n (%) 9 948 (30.3) 9 117 (91.7) 831 (8.4) 
 Other Mechanisms, n (% ) 12 365 (3.9) 131 819 (96.5) 4 795 (3.5) 
Payer Status at Discharge       
 Medicare/Medicaid, n (% ) 142 424 (32.5) 135 832 (95.4) 6 592 (4.6) 
 Private insurance, n (% ) 118 565 (27.1) 115 632 (97.5) 2 942 (2.5) 
 Other insurance, n (%) 33 850 (7.7) 32 422 (95.8) 1 428 (4.2) 
 Uninsured, n (% ) 77 266 (17.6) 74 608 (96.6) 2 658 (3.4) 
 Insurance status unknown, n (% ) 65 953 (15.1) 63 643 (96.5) 2 310 (3.5) 
Length of Stay, mean (SD) 6.5 (9.3) 6.5 (9.2) 6.9 (11.9) 
ICU Admission, n (%) 138 837 (31.7) 125 697 (90.5) 13 140 (9.5) 
 ICU length of stay, days mean (SD) 5.6 (7.8) 5.6 (7.7) 5.8 (8.9) 
 Mechanical ventilation, days mean (SD) 6.4 (9.2) 6.7 (9.4) 5.2 (8.7) 
Injury Severity Score, mean (SD) 12.1 (9.6) 11.6 (8.9) 27.4 (14.5) 
Mortality Prediction models, mean (SD)       
 TMPM, probability of death 0.036 (0.092) 0.027 (0.062) 0.271 (0.269) 
 TARN, probability of death 0.011 (0.036) 0.011 (0.032) 0.106 (0.146) 
 *p<0.05 for all comparisons 
 
 
 
 
 
 
Table 2. Area under the ROC curve and AIC values for TARN and TMPM
 
 
 AUROC (95% CI) AIC (95% CI) HL (95% CI) 
DERIVATION 
TARN 0.841 (0.840-0.841) 86 980 (86 942-87 019) 684.6 (681.3-687.8) 
TMPM 0.880 (0.880-0.880) 74 509 (74 773-74545) 90.6 (89.4-91.7) 
VALIDATION 
TARN 0.845 (0.845-0.846) 21 163 (21 143-21 182) 153.0 (151.6-154.3) 
     TMPM 0.882 (0.882-0.882) 18 204 (18 186-18 223) 32.4 (31.7-33.1) 
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    Figure 1. Flow diagram of patients excluded by criteria 
 
 Figure 2. Calibration curve for the anatomic components of TARN and TMPM models: Derivation  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Calibration curve for the anatomic components of TARN and TMPM models: Validation 
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